COVID Update: Recalibrating the Vaccine Rollout in Light of new Clotting Cases

Healthed

writer

Healthed

Claim CPD for this activity

Educational Activities (EA)
0 minutes

These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

Reviewing Performance (RP)
0 minutes

These are activities that require reflection on feedback about your work.

Measuring Outcomes (MO)
0 minutes

These are activities that use your work data to ensure quality results.

EA
0 minutes

These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

RP
0 minutes

These are activities that require reflection on feedback about your work.

MO
0 minutes

These are activities that use your work data to ensure quality results.

Healthed

Over the past 72 hours, three more Australian cases of clotting that appear to be connected to the AZ vaccine have been reported. Patients are obviously very concerned and this is leading to many queries at clinics and increased hesitancy.

The condition – known as vaccine-induced prothrombotic immune thrombocytopenia (VIPIT) looks similar to heparin-induced thrombocytopenia, causing clotting in various parts of the body.

Generally it occurs 4-20 days after the first dose of the AstraZeneca vaccine. No cases have occurred after the second dose.

The Covid vaccine programme has recently changed in line with these developments and current target dates for our vaccine rollout have needed to be recalibrated in light of new vaccine recommendations for people under age 50 to have the Pfizer vaccine. For patients having the AstraZeneca vaccine, new consent forms include questions about history of thrombosis and thrombocytopenia.

Learn about these and other important developments in the upcoming Healthed webcast featuring Associate Professor Nicholas Wood from the National Centre for Research and Surveillance.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
A/Prof Karam Kostner

A/Prof Karam Kostner

LDL Management – Why it is Important

A/Prof Ralph Audehm

A/Prof Ralph Audehm

Navigating Expanded PBS Access to SGLT2i in General Practice

Prof Deborah Bateson

Prof Deborah Bateson

Cervical Cancer Prevention – Common Questions

Clinical A/Prof Greg Katsoulotos

Clinical A/Prof Greg Katsoulotos

Asthma Cases – When to Use Dual vs Triple Therapy

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Share this

Share this

Healthed

writer

Healthed

Test your knowledge

Recent articles

Latest GP poll

In your opinion, will the mass resignation of psychiatrists in NSW prompt government action?

Yes

0%

No

0%

Recent podcasts

Listen to expert interviews.
Click to open in a new tab

Find your area of interest

Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.

Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.